Physician profile
Patrick Jordan
NPI 1922425487
$3,636.27
in general payments reported to CMS, 2019-2025
19 companies · $435 in 2025
The $435 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,509 · 2020: $201 · 2021: $84.05 · 2022: $1,269 · 2024: $139 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,302.05 | 2022-2025 | Ankle Fracture, Monkey Rings |
| Zimmer Biomet Holdings, INC. | $826.49 | 2019 | |
| Medical Device Business Services, INC. | $338.15 | 2019 | |
| Depuy Synthes Sales INC. | $239.96 | 2019-2021 | |
| Smith+Nephew, INC. | $235.51 | 2019-2025 | Collagenase Santyl |
| Stryker Corporation | $208.80 | 2024-2025 | Augment Injectable, Ortholoc 2 Lapifuse, N/A |
| Acell, INC. | $152.76 | 2020 | |
| Bioventus LLC | $53.99 | 2019 | |
| Treace Medical Concepts, INC. | $41.92 | 2024 | |
| Paratek Pharmaceuticals, INC. | $40.96 | 2024-2025 | Nuzyra |
| Organogenesis INC. | $34.08 | 2021 | |
| Kci USA, INC. | $33.88 | 2020 | |
| Averitas Pharma INC. | $25.62 | 2025 | Qutenza |
| Orthofix Medical, INC. | $23.34 | 2025 | Physio-Stim |
| Ebi, LLC | $17.19 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Highridge Medical LLC | $17.19 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Abbvie INC. | $15.97 | 2021 | |
| Heron Therapeutics, INC. | $14.73 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $13.68 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.